Citations

Clear

4207 citation(s) found for "Yu, Chen".

Evolution of distal limb perfusion management in adult peripheral venoarterial extracorporeal membrane oxygenation with femoral artery cannulation
Simons, Jorik , Fraser, John F. , Zaaqoq, Akram , Cho, Sung‐Min , Patel, B. M. , Brodie, Daniel , Jung, Jae Seung , Salazar, Leonardo, Meani, Paolo , Mariani, Silvia , Yannopoulos, Demetris , Broman, Lars Mikael , Chen, Yih‐Sharng , Riera, Jordi , Mook, Walther van , Zaaqoq, Akram M , Cho, Sung-Min , Meani, Paolo , Chen, Yih-Sharng , Riera, Jordi , Lorusso, Roberto , Mees, Barend M.E. , MacLaren, Graeme , Bělohlávek, Jan , Belliato, Mirko , Mauro, Michele Di , Lorusso, Roberto

Mayo Clinic

Perfusion | April 23, 2024 | Volume: 39 | Issue: 1_suppl | Pages: 23S-38S

10.1177/02676591241236650 | PMID 38651584 Get It

Limb ischaemia is a clinically relevant complication of venoarterial extracorporeal membrane oxygenation (VA ECMO) with femoral artery cannulation. No selective distal perfusion or other advanced techniques were used in the past to maintain adequate distal limb perfusion. A more recent trend is the shift from the reactive or emergency management to the pro-active or prophylactic placement of a distal perfusion cannula to avoid or reduce limb ischaemia-related complications. Multiple alternative cannulation techniques to the distal perfusion cannula have been developed to maintain distal limb perfusion, including end-to-side grafting, external or endovascular femoro-femoral bypass, retrograde limb perfusion (e.g., via the posterior tibial, dorsalis pedis or anterior tibial artery), and, more recently, use of a bidirectional cannula. Venous congestion has also been recognized as a potential contributing factor to limb ischaemia development and specific techniques have been described with facilitated venous drainage or bilateral cannulation being the most recent, to reduce or avoid venous stasis as a contributor to impaired limb perfusion. Advances in monitoring techniques, such as near-infrared spectroscopy and duplex ultrasound analysis, have been applied to improve decision-making regarding both the monitoring and management of limb ischaemia. This narrative review describes the evolution of techniques used for distal limb perfusion during peripheral VA ECMO.
ARISE I Consensus Statement on the Management of Chronic Subdural Hematoma
Kan, Peter , Fiorella, David , Dabus, Guilherme , Samaniego, Edgar A. , Lanzino, Giuseppe , Siddiqui, Adnan H. , Chen, Huanwen , Khalessi, Alexander A. , Fifi, Johanna T , Bain, Mark, Wakhloo, Ajay K. , Roundtable, on behalf of the ARISE I Academic Industry, Fifi, Johanna T , Colby, Geoffrey P , Wakhloo, Ajay K , Fiorella, David , Siddiqui, Adnan H , Samaniego, Edgar A , Lanzino, Giuseppe , Dabus, Guilherme C. , Mendes Pereira, Vitor , Colby, Geoffrey P. , Arthur, Adam Stephen , Roundtable, on behalf of the ARISE I Academic Industry, Chen, Huanwen

Mayo Clinic

Stroke | April 22, 2024 | Volume: 55 | Issue: 5 | Pages: 1438-1448

10.1161/strokeaha.123.044129 | PMID 38648281 Get It

ARISE (Aneurysm/AVM/cSDH Roundtable Discussion With Industry and Stroke Experts) organized a one-and-a-half day meeting and workshop and brought together representatives from academia, industry, and government to discuss the most promising approaches to improve outcomes for patients with chronic subdural hematoma (cSDH). The emerging role of middle meningeal artery embolization in clinical practice and the design of current and potential future trials were the primary focuses of discussion. Existing evidence for imaging, indications, agents, and techniques was reviewed, and areas of priority for study and key questions surrounding the development of new and existing treatments for cSDH were identified. Multiple randomized, controlled trials have met their primary efficacy end points, providing high-level evidence that middle meningeal artery embolization is a potent adjunctive therapy to the standard (surgical and nonsurgical) management of neurologically stable cSDH patients in terms of reducing rates of disease recurrence. Pooled data analyses following the formal conclusion and publication of these trials will form a robust foundation upon which guidelines can be strengthened for cSDH treatment modalities and optimal patient selection, as well as delineate future lines of investigation.
USP19 regulates DNA methylation damage repair and confers temozolomide resistance through MGMT stabilization
Liu, Jiaqi , Zhu, Qian , Zhang, Yixin , Chen, Yuping , Wang, Kaikai , Lou, Zhenkun , Yuan, Jian

Mayo Clinic

CNS Neuroscience & Therapeutics | April 22, 2024 | Volume: 30 | Issue: 4 | Pages: No page available

10.1111/cns.14711 | PMID 38644551 Get It

AbstractObjectiveTo elucidate the relationship between USP19 and O(6)‐methylguanine‐DNA methyltransferase (MGMT) after temozolomide treatment in glioblastoma (GBM) patients with chemotherapy resistance.MethodsScreening the deubiquitinase pannel and identifying the deubiquitinase directly interacts with and deubiquitination MGMT. Deubiquitination assay to confirm USP19 deubiquitinates MGMT. The colony formation and tumor growth study in xenograft assess USP19 affects the GBM sensitive to TMZ was performed by T98G, LN18, U251, and U87 cell lines. Immunohistochemistry staining and survival analysis were performed to explore how USP19 is correlated to MGMT in GBM clinical management.ResultsUSP19 removes the ubiquitination of MGMT to facilitate the DNA methylation damage repair. Depletion of USP19 results in the glioblastoma cell sensitivity to temozolomide, which can be rescued by overexpressing MGMT. USP19 is overexpressed in glioblastoma patient samples, which positively correlates with the level of MGMT protein and poor prognosis in these patients.ConclusionThe regulation of MGMT ubiquitination by USP19 plays a critical role in DNA methylation damage repair and GBM patients’ temozolomide chemotherapy response.
0625 Prevalence of Subjective Longer Sleep Times and Sleepiness in Patients Evaluated at a Tertiary Medical Center
Chen, Xindi, Ruoff, Chad , Ruoff, Chad M , Buras, Matthew , Carvalho, Diego Z.

Mayo Clinic

SLEEP | April 20, 2024 | Volume: 47 | Issue: Supplement_1 | Pages: A267-A267

10.1093/sleep/zsae067.0625 Get It

Abstract Introduction The ICSD-3-TR defines idiopathic hypersomnia in terms of objective sleep times as sleeping at least 11 hours using 24-hour polysomnography or wrist actigraphy averaged over at least 7 days. Published studies on sleep duration are generally limited by lower sleep duration cut-offs (e.g., ≥ 9 hours), so prevalence data on longer sleep durations are missing. This study used clinical questionnaire data from Mayo Clinic patients to characterize longer sleep times and excessive daytime sleepiness in this population. Methods We retrospectively identified patients who answered questions about subjective sleep times and excessive daytime sleepiness, using the Epworth Sleepiness Scale (ESS), as part of their evaluation in a sleep clinic across the Mayo Clinic Enterprise from 2017 to 2023. Demographic data and sleep disorder diagnoses were then analyzed. Results Patients (N=25,480) with subjective nocturnal sleep times of ≥ 9 (n=2721, 10.7%), ≥ 10 (n=1059, 4.2%), and ≥ 11 hours (n=349, 1.4%) had an ESS ≥ 10 in 33.5%, 41.0%, and 51.3% of the time, respectively. 3.6% (age 53.2±19.7; 58.9% female), 1.7% (age 53.1±20.4; 58.1% female), and 0.7% (age 49.8±19.9; 58.1% female) of the patients reported an ESS ≥ 10 and subjective nocturnal sleep times of ≥ 9, ≥ 10, and ≥ 11 hours per night, respectively. After adjusting for age and sex, patients with more than one diagnostic entry compared to those with one or fewer diagnostic entries for idiopathic hypersomnia with long sleep time (OR=12.75, 95% CI [6.09, 24.52], p< 0.001) and narcolepsy with cataplexy (OR=5.53, 95% CI [1.31, 15.84], p=0.005) were significantly more likely to report ESS ≥ 10 and subjective nocturnal sleep times ≥ 11 hours per night. Conclusion Less than 1% of patients presenting to a Mayo Clinic sleep specialist have self-reported metrics (i.e., ESS ≥ 10 and subjective nocturnal sleep times ≥ 11 per night) consistent with basic clinical features of idiopathic hypersomnia with long sleep time. Additional data analyses (e.g., comorbid conditions, social history, and laboratory results) are underway. Support (if any)
Anesthetic Considerations for Patients with Hereditary Neuropathy with Liability to Pressure Palsies: A Narrative Review
Laudański, Krzysztof , Elmadhoun, Omar, Mathew, Amal , Kahn-Pascual, Yul, Kerfeld, Mitchell J. , Chen, James L. , Sisniega, Daniella , Gomez, Francisco

Mayo Clinic

Healthcare | April 19, 2024 | Volume: 12 | Issue: 8 | Pages: 858

10.3390/healthcare12080858 | PMID 38667620 Get It

Hereditary neuropathy with liability to pressure palsies (HNPP) is an autosomal dominant demyelinating neuropathy characterized by an increased susceptibility to peripheral nerve injury from trauma, compression, or shear forces. Patients with this condition are unique, necessitating distinct considerations for anesthesia and surgical teams. This review describes the etiology, prevalence, clinical presentation, and management of HNPP and presents contemporary evidence and recommendations for optimal care for HNPP patients in the perioperative period. While the incidence of HNPP is reported at 7–16:100,000, this figure may be an underestimation due to underdiagnosis, further complicating medicolegal issues. With the subtle nature of symptoms associated with HNPP, patients with this condition may remain unrecognized during the perioperative period, posing significant risks. Several aspects of caring for this population, including anesthetic choices, intraoperative positioning, and monitoring strategy, may deviate from standard practices. As such, a tailored approach to caring for this unique population, coupled with meticulous preoperative planning, is crucial and requires a multidisciplinary approach.
The Effect of C2 Muscular Exposure Technique on Radiographic and Clinical Outcomes After C2–T2 Posterior Cervical Fusion
Pumford, Andrew, Townsley, Sarah, Reed, Ryder, Chen, Selby , Deen, H. Gordon , Bydon, Mohamad , Fogelson, Jeremy L. , Elder, Benjamin D. , Currier, Bradford L. , Freedman, Brett A. , Sebastian, Arjun S. , Katsos, Konstantinos, Clarke, Michelle, Levy, Hannah A. , Pinter, Zachariah W. , Salmons, Harold I. , Katsos, Konstantinos, Abode-Iyamah, Kingsley , Clarke, Michelle J. , Nassr, Ahmad , Karamian, Brian A.

Mayo Clinic

Clinical Spine Surgery | April 19, 2024 | Volume: 37 | Issue: 10 | Pages: E448-E454

10.1097/bsd.0000000000001626 | PMID 38637921 Get It

Study Design: Retrospective cohort analysis. Objective: To determine whether the C2 exposure technique was a predictor of change in cervical alignment and patient-reported outcomes measures (PROMs) after posterior cervical decompression and fusion (PCDF) for degenerative indications. Background: In PCDF handling of the C2 posterior paraspinal musculature during the operative approach varies by surgeon technique. To date, no studies have investigated whether maintenance of the upper cervical semispinalis cervicis attachments as compared with complete reflection of upper cervical paraspinal musculature from the posterior bony elements is associated with superior radiographic and clinical outcomes after PCDF. Patients and Methods: All adult patients who underwent C2–T2 PCDF for myelopathy or myeloradiculopathy at multi-institutional academic centers between 2013 and 2020 were retrospectively identified. Patients were dichotomized by the C2 exposure technique into semispinalis preservation or midline muscular reflection groups. Preoperative and short and long-term postoperative radiographic outcomes (upper cervical alignment, global alignment, and fusion status) and PROMs (Visual Analog Scale–Neck, Neck Disability Index, and Short Form-12) were collected. Univariate analysis compared patient factors, radiographic measures, and PROMs across C2 exposure groups. Results: A total of 129 patients met the inclusion/exclusion criteria (73 muscle preservation and 56 muscle reflection). Patients in the muscular preservation group were on average younger (P = 0.005) and more likely to have bone morphogenic protein (P < 0.001) and C2 pars screws (P = 0.006) used during surgery. Preoperative to postoperative changes in C2 slope, C2 tilt, C2–C3 segmental lordosis, C2–C3 listhesis, C0–C2 Cobb angle, proximal junctional kyphosis, ADI, C1 lamina-occiput distance, C2 sagittal vertical axis, C2–C7 lordosis, and PROMs at all follow-up intervals did not vary significantly by C2 exposure technique. Likewise, there were no significant differences in fusion status, C2–C3 pseudoarthrosis, C2 screw loosening, and complication and revision rates between C2 exposure groups. Conclusions: Preservation of C2 semispinalis attachments versus muscular reflection did not significantly impact cervical alignment, clinical outcomes, or proximal junction complications in long-segment PCDF. Level of Evidence: Level III.
Mapping Proximity to Infectious Disease Physicians Across the United States
Maamari, Julian , Chen, Zhuo , Motairek, Issam , Al‐Kindi, Sadeer , Fleisher, Jorge , Maamari, Julian

Mayo Clinic

Open Forum Infectious Diseases | April 18, 2024 | Volume: 11 | Issue: 5 | Pages: No page available

10.1093/ofid/ofae208 | PMID 38737425 Get It

Abstract Enduring shortages of infectious disease physicians across the United States continue despite efforts to mitigate the problem. The recent fellowship match results underscore the difficulty in rectifying that shortage. Our report sheds light on the current geographic distribution of US infectious disease physicians and highlights the challenges faced by rural communities.
The ARPKD Protein DZIP1L Regulates Ciliary Protein Entry by Modulating the Architecture and Function of Ciliary Transition Fibers
Chen, Huicheng , Wu, Zhimao, Yan, Ziwei , Chen, Chuan , Zhang, Yingying , Wang, Qiaoling, Gao, Yuqing, Ling, Kun , Hu, Jinghua , Wei, Qing , Chen, Chuan , Wang, Qiaoling, Gao, Yuqing

Mayo Clinic

Advanced Science | April 18, 2024 | Volume: 11 | Issue: 24 | Pages: No page available

10.1002/advs.202308820 | PMID 38634253 Get It

AbstractServing as the cell's sensory antennae, primary cilia are linked to numerous human genetic diseases when they malfunction. DZIP1L, identified as one of the genetic causes of human autosomal recessive polycystic kidney disease (ARPKD), is an evolutionarily conserved ciliary basal body protein. Although it has been reported that DZIP1L is involved in the ciliary entry of PKD proteins, the underlying mechanism remains elusive. Here, an uncharacterized role of DZIP1L is reported in modulating the architecture and function of transition fibers (TFs), striking ciliary base structures essential for selective cilia gating. Using C. elegans as a model, C01G5.7 (hereafter termed DZIP‐1) is identified as the sole homolog of DZIP1L, which specifically localizes to TFs. While DZIP‐1 or ANKR‐26 (the ortholog of ANKRD26) deficiency shows subtle impact on TFs, co‐depletion of DZIP‐1 and ANKR‐26 disrupts TF assembly and cilia gating for soluble and membrane proteins, including the ortholog of ADPKD protein polycystin‐2. Notably, the synergistic role for DZIP1L and ANKRD26 in the formation and function of TFs is highly conserved in mammalian cilia. Hence, the findings illuminate an evolutionarily conserved role of DZIP1L in TFs architecture and function, highlighting TFs as a vital part of the ciliary gate implicated in ciliopathies ARPKD.
Family characteristics and childcare patterns associated with early social functioning in cancer‐bereaved parents
Snaman, Jennifer M. , Helton, Gabrielle, Feifer, Deborah , Baker, Justin N. , McCarthy, Sarah , Rosenberg, Abby R , Chen, Li , Mazzola, Emanuele , Broden, Elizabeth G. , Rosenberg, Abby R. , Wolfe, Joanne

Mayo Clinic

Cancer | April 15, 2024 | Volume: 130 | Issue: 16 | Pages: 2822-2833

10.1002/cncr.35325 | PMID 38620040 Get It

AbstractBackgroundBereaved parents experience life‐long grief after the death of their child from cancer. Parents who can integrate their grief and maintain their social functioning early in bereavement, even in the setting of concurrent psychosocial distress, have improved outcomes. Identifying the factors associated with bereaved parents' early social functioning can guide future supportive interventions.MethodsThe authors surveyed parents of children who died from cancer at two large centers 6–24 months after death, assessing bereavement experiences using validated and pilot tested tools. Univariable and multivariable logistical regression models were used to examine which family and child demographic, treatment, and end‐of‐life (EOL) factors were associated with maintained parental social functioning (T scores ≥40 on the Patient‐Reported Outcomes Measurement Information System Ability to Participate in Social Roles and Activities‐Short Form questionnaire).ResultsOne hundred twenty‐eight parents of 88 children participated (38% household response rate); most parents identified as female (63%) and White (88%). Parents' median age was 47 years (interquartile range, 10 years); and the median time from the child's death to survey completion was 13 months (interquartile range, 10 months). In multivariate modeling, parents without household material hardship and those who felt prepared for EOL circumstances had increased odds of maintained social functioning (odds ratio, 4.7 [95% confidence interval, 1.6–13.7; p < .004] and 5.5 [95% confidence interval, 1.9–15.9; p < .002], respectively).ConclusionsParents who felt prepared for their child's EOL and those without household material hardship were more likely to have maintained social functioning in the first 2 years after their child’s death. Interventions targeting EOL preparedness and alleviating household material hardship may improve bereavement outcomes.
CircBCL2L13 attenuates cardiomyocyte oxidative stress and apoptosis in cardiac ischemia‒reperfusion injury via miR‐1246/PEG3 signaling
Wu, Hua , Li, Hairui , Song, Jia , Chen, Yongbin , Wang, Ze‐Mu , Jiang, Weipeng , Jiang, Weipeng , Wu, Hua, Zhang, Qian

Mayo Clinic

Journal of Biochemical and Molecular Toxicology | April 12, 2024 | Volume: 38 | Issue: 4 | Pages: No page available

10.1002/jbt.23711 | PMID 38605443 Get It

AbstractIschemia‒reperfusion (I/R) is a common complication in the clinical treatment of acute myocardial infarction (MI), in which cardiomyocytes play a pivotal role in the recovery of cardiac function after reperfusion injury. The expression of numerous circular ribonucleic acids (circRNAs) is disrupted in I/R‐induced cardiac damage, but the potential role of circRNAs in I/R damage has not been fully elucidated. The purpose of the present study was to clarify the biological action and molecular mechanism of circRNA 002166 (also termed circCL2L13) in postmyocardial I/R. Oxygen–glucose deprivation/reoxygenation (OGD/R) in an in vivo model was performed to simulate I/R damage. real‐time polymerase chain reaction analysis was also conducted to evaluate the relationships of the SOD1, SOD2, NRF2, HO1 and GPX4 indicators with oxidative stress injury. TUNEL immunofluorescence was used to evaluate the degree of cardiomyocyte apoptosis in the different treatment groups. The circBCL2L13 level was markedly upregulated in myocardial tissues from a mouse I/R model. Overexpression of circBCL2L13 markedly attenuated the expression of oxidative stress‐related genes and apoptosis in OGD/R‐induced cardiomyocytes. A mechanistic study revealed that circBCL2L13 functions as a ceRNA for miR‐1246 and modulates paternally expressed gene 3 (PEG3). Eventually, circBCL2L13 was proven to regulate PEG3 by targeting miR‐1246, thereby protecting against OGD/R‐induced cardiomyocyte oxidative damage and apoptosis. In conclusion, our study confirmed that the circBCL2L13/miR‐1246/PEG3 axis suppressed the progression of OGD/R injury in cardiomyocytes, which might lead to new therapeutic strategies for cardiac I/R injury.